Lipidomic profiling reveals medium-chain acylcarnitines alterations as metabolic signatures in IgA nephropathy

Abstract Immunoglobulin A nephropathy (IgAN), the most common primary glomerulonephritis worldwide, exhibits highly variable clinical progression, ranging from asymptomatic urinary abnormalities with potential for spontaneous resolution to progressive kidney failure over 10–20 years. The limited und...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jiawei Cheng, Yuanyuan Han, Yan Zhang, Xin He, Sijue Zou, Wenzhe She, Zhangzhe Peng, Ling Huang, Hao Huang
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2026-02-01
Serija:	BMC Nephrology
Teme:	IgA nephropathy Widely targeted lipidomics Medium-chain acylcarnitines Carnitine
Online dostop:	https://doi.org/10.1186/s12882-026-04822-3
Oznake:	Označite Brez oznak, prvi označite!